Results 151 to 160 of about 59,855 (258)

Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. [PDF]

Neuropsychopharmacol Rep
Saga Y, Horio H, Chiang CL, Wakamatsu A.
europepmc   +1 more source

Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder

Neurotherapeutics, 2013
L. Cloud, Deepti Zutshi, S. Factor
semanticscholar   +1 more source

A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation. [PDF]

Sci Rep
Ishida M, Ichikawa R, Ohbuchi K, Oizumi H, Miyamoto Y, Yamauchi J.   +5 more
europepmc   +1 more source

The real-world multidimensional impact of tardive dyskinesia: interim results from an observational, multicentre, registry study

Marco J. Konings, Steven Finkbeiner, Krzysztof Duma, Richard Jackson   +3 more
openalex   +1 more source

Tardive dyskinesia treated with manganese.

, 1977
A. Hoffer
openalex  

Identifying the diagnostic gap of tardive dyskinesia: an analysis of semi-structured electronic health record data. [PDF]

BMC Psychiatry
Griffiths K, Won Y, Lee Z, Wang L, Correll CU, Patel R.   +5 more
europepmc   +1 more source

Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease. [PDF]

Neurol Ther
Frank S, Anderson KE, Fernandez HH, Hauser RA, Claassen DO, Stamler D, Factor SA, Jimenez-Shahed J, Barkay H, Wilhelm A, Alexander JK, Chaijale N, Barash S, Savola JM, Gordon MF, Chen M.   +15 more
europepmc   +1 more source

Treatment of tardive dyskinesia with clonazepam: A case report. [PDF]

Clin Case Rep
Chhetri B, Gyeltshen D.
europepmc   +1 more source

Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder

Mieko Nagano, Yutaka Susuta, Hideaki Masui, Yumi Watanabe, Koichiro Watanabe   +4 more
openalex   +1 more source

Dissemination of VMAT-2 Inhibitors: A New Class Drug for Tardive Dyskinesia and Huntington Disease. [PDF]

Neurol Clin Pract
Ma E, Krening E, Bruno MK.
europepmc   +1 more source